INCIDENCE OF HELICOBACTER PYLORI INFECTIONS AMONG THE PATIENTS WITH ULCER AND NON-ULCER DYSPEPSIA

Lj. Stalević ,
Lj. Stalević

Infective Clinic, CHC Priština , Priština , Kosovo*

M. Popović ,
M. Popović

Internal Clinic, Medical faculty Priština , Kosovska Mitrovica , Kosovo*

D. Aleksovski ,
D. Aleksovski

Internal Clinic, CHC Priština Kosovo*

J. Mitić ,
J. Mitić

Internal Clinic, CHC Priština Kosovo*

D. Sotirović
D. Sotirović

Internal Clinic, CHC Priština Kosovo*

Published: 01.01.2010.

Volume 38, Issue 1 (2010)

pp. 117-119;

https://doi.org/10.70949/pramed201001339S

Abstract

Helicobacter pylori infection is the largest number of infected people in the world. It is believed that 50 - 60% of world population infected, but with uneven schedule. Helicobacter pylori is the most important cause of duodenal and gastric ulcer. The prevalence of infection in different communities vary depending on geographic, racial and socioeconomic factors, and the last 10-20 years in some areas can be observed a significant reduction in the frequency of infection in both the general population and among patients with peptic ulcer. In our country, except in the territory of Vojvodina, there was no serious investigation of frequency of Helicobacter pylori infection in the general population.

Keywords

References

1.
Milosavljević T. Uvod (istorijat i epidemiologija infekcije Helicobacter pylori. Acta Clinica. 2(1):9–13.
2.
Grgov S. Helicobacter pylori infekcije: Patogeneza i kliničke posledice.
3.
Popović M. Gastroenterologija dijagnostika i terapija.
4.
Marshall BJ. Helicobacter pylori: The etiologic agent for peptic ulcer. JAMA. 274:1064–6.
5.
Joytheeswaran S, Shah AN, Jin HO, Potter GD, Ona FV, Chey WY. Prevalence of Helicobacter pylori in peptic ulcer patients in Greater Rochester, NY: Is empirical triple therapy justified? Am J Gastroenterol. 93(4):574–8.
6.
Chen J, Bu XL, Wang QZ, Hu PJ, Chen MH. Decreasing seroprevalence of Helicobacter pylori infection during 1993-2003 in Guangzhou, southern China. Epidemiol Infect. 119(1):29–34.
7.
Ljevaja M, Mrdja Z. Učestalost Helicobacter infekcije kod bolesnika sa ulkusnom i neulkusnom dispepsijom. Esculap. 1,2:50–3.
8.
Banatvala N, Mayo K, Megraud F, Jernings R, Deeks JJ, Feldman RA. The cohort effect and Helicobacter pylori. BMC Gastroenterol. 2:1.
9.
Adamopoulos AB, Efstathiou SP, Tsioulos DI. Bleeding duodenal ulcer: Comparison between Helicobacter pylori positive and Helicobacter pylori negative bleeders. Dig Liver Dis. 36:13–20.
10.
Ramsoekh D, Leerdam ME, Rauws EA. Outcome of peptic ulcer bleeding, nonsteroidal anti-inflammatory drug use, and Helicobacter pylori infection. Clin Gastroenterol Hepatol. 3:859–64.
11.
Kiltz U, Zochling J, Schmidt WE, Braun J. Use of NSAIDs and infection with Helicobacter pylori: What does the rheumatologist need to know? Rheumatology (Oxford. 47:1342–7.

Citation

Copyright

Article metrics

Google scholar: See link

The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Most read articles

Indexed by